Caring Brands (CABR) Return on Sales (2024 - 2025)
Caring Brands' (CABR) quarterly Return on Sales came in at 23.56% in Q4 2025, down 500.0% year-on-year from 5.89% in Q4 2024, and down 5.87% quarter-over-quarter from 22.25% in Q3 2025.
Caring Brands (CABR) Return on Sales (2024 - 2025) Analysis & Trends
Caring Brands' Return on Sales history runs 2 years deep, the most recent figure standing at 23.56% for Q4 2025.
- On a quarterly basis, Return on Sales fell 500.0% year-over-year to 23.56% in Q4 2025; TTM through Dec 2025 was 15.93%, a N/A change from a year earlier, with the FY2025 full-year figure at 17.64%, changed N/A from the prior year.
- Return on Sales fell to 23.56% in Q4 2025 per CABR's latest filing, from 22.25% in the prior quarter.
- Across five years, Return on Sales topped out at 3.67% in Q1 2025 and bottomed at 23.56% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -0.01% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00% |
| 10 | Caring Brands | 20.08 Mn | 21.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23.56% |
| Sep 30, 2025 | -22.25% |
| Mar 31, 2025 | -3.67% |
| Dec 31, 2024 | -18.55% |